{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T17:07:52Z","timestamp":1778605672319,"version":"3.51.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,12]]},"DOI":"10.7759\/cureus.108728","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T16:11:03Z","timestamp":1778602263000},"source":"Crossref","is-referenced-by-count":0,"title":["Myeloperoxidase Antineutrophil Cytoplasmic Antibody (MPO-ANCA)-Associated Usual Interstitial Pneumonia: Pathogenic Mechanisms, Diagnostic Challenges, and Clinical Implications"],"prefix":"10.7759","author":[{"given":"Stephanie Johanna","family":"Chon Pineda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana","family":"Baron-Anaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Arroyo-Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana-Paola","family":"Puente-Gutu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alvaro Paul","family":"Calvo-Cant\u00fa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dante","family":"Arroyo-Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Fernanda","family":"Aguirre Quintero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso","family":"Sandoval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley","family":"Guzm\u00e1n Vel\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Emiliano","family":"Gonz\u00e1lez Flores","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0199659","article-title":"Clinical significance of myeloperoxidase-anti-neutrophil cytoplasmic antibody in idiopathic interstitial pneumonias","volume":"13","author":"Hozumi H","year":"2018","unstructured":"Hozumi H, Oyama Y, Yasui H, et al.. Clinical significance of myeloperoxidase-anti-neutrophil cytoplasmic antibody in idiopathic interstitial pneumonias. PLoS One. 2018, 13:e0199659. 10.1371\/journal.pone.0199659","journal-title":"PLoS One"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202202-0399ST","article-title":"Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"205","author":"Raghu G","year":"2022","unstructured":"Raghu G, Remy-Jardin M, Richeldi L, et al.. Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2022, 205:e18-47. 10.1164\/rccm.202202-0399ST","journal-title":"Am J Respir Crit Care Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.36141\/svdld.v38i4.11808","article-title":"MPO-ANCA positive interstitial pneumonia: current knowledge and future perspectives","volume":"38","author":"Bando M","year":"2022","unstructured":"Bando M, Homma S, Harigai M. MPO-ANCA positive interstitial pneumonia: current knowledge and future perspectives. Sarcoidosis Vasc Diffuse Lung Dis. 2022, 38:e2021045. 10.36141\/svdld.v38i4.11808","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-021-01451-4","article-title":"Clinical features and long-term outcomes of interstitial lung disease with anti-neutrophil cytoplasmic antibody","volume":"21","author":"Sun X","year":"2021","unstructured":"Sun X, Peng M, Zhang T, Li Z, Song L, Li M, Shi J. Clinical features and long-term outcomes of interstitial lung disease with anti-neutrophil cytoplasmic antibody. BMC Pulm Med. 2021, 21:88. 10.1186\/s12890-021-01451-4","journal-title":"BMC Pulm Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2019.102338","article-title":"Usual interstitial pneumonia in ANCA-associated vasculitis: a poor prognostic factor","volume":"106","author":"Maillet T","year":"2020","unstructured":"Maillet T, Goletto T, Beltramo G, et al.. Usual interstitial pneumonia in ANCA-associated vasculitis: a poor prognostic factor. J Autoimmun. 2020, 106:102338. 10.1016\/j.jaut.2019.102338","journal-title":"J Autoimmun"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0094775","article-title":"Usual interstitial pneumonia preceding collagen vascular disease: a retrospective case control study of patients initially diagnosed with idiopathic pulmonary fibrosis","volume":"9","author":"Kono M","year":"2014","unstructured":"Kono M, Nakamura Y, Enomoto N, et al.. Usual interstitial pneumonia preceding collagen vascular disease: a retrospective case control study of patients initially diagnosed with idiopathic pulmonary fibrosis. PLoS One. 2014, 9:e94775. 10.1371\/journal.pone.0094775","journal-title":"PLoS One"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-021-01718-w","article-title":"Prognostic value of radiological findings indeterminate for UIP pattern and anterior upper lobe honeycomb-like lesion in chronic fibrosing interstitial lung disease associated with MPO-ANCA","volume":"21","author":"Yamakawa H","year":"2021","unstructured":"Yamakawa H, Sato S, Nakamura T, et al.. Prognostic value of radiological findings indeterminate for UIP pattern and anterior upper lobe honeycomb-like lesion in chronic fibrosing interstitial lung disease associated with MPO-ANCA. BMC Pulm Med. 2021, 21:346. 10.1186\/s12890-021-01718-w","journal-title":"BMC Pulm Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.36141\/svdld.v37i1.7980","article-title":"Interstitial lung disease and microscopic polyangiitis in chilean patients","volume":"37","author":"Wurmann P","year":"2020","unstructured":"Wurmann P, Sabugo F, Elgueta F, et al.. Interstitial lung disease and microscopic polyangiitis in chilean patients. Sarcoidosis Vasc Diffuse Lung Dis. 2020, 37:37-42. 10.36141\/svdld.v37i1.7980","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4137\/CCRPM.S23314","article-title":"Interstitial lung disease with ANCA-associated vasculitis","volume":"9","author":"Katsumata Y","year":"2015","unstructured":"Katsumata Y, Kawaguchi Y, Yamanaka H. Interstitial lung disease with ANCA-associated vasculitis. Clin Med Insights Circ Respir Pulm Med. 2015, 9:51-6. 10.4137\/CCRPM.S23314","journal-title":"Clin Med Insights Circ Respir Pulm Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2024.152484","article-title":"Progression to ANCA-associated vasculitis in patients with idiopathic interstitial pneumonia and positive ANCA","volume":"68","author":"Lee YJ","year":"2024","unstructured":"Lee YJ, Kim HC, Ahn SM, et al.. Progression to ANCA-associated vasculitis in patients with idiopathic interstitial pneumonia and positive ANCA. Semin Arthritis Rheum. 2024, 68:152484. 10.1016\/j.semarthrit.2024.152484","journal-title":"Semin Arthritis Rheum"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2025.152726","article-title":"Interstitial lung disease in patients with antineutrophil cytoplasmic antibody-associated vasculitis: chest CT patterns and correlation with survival","volume":"73","author":"Casal Moura M","year":"2025","unstructured":"Casal Moura M, Tandon YK, Hartman TE, Ryu JH, Baqir M. Interstitial lung disease in patients with antineutrophil cytoplasmic antibody-associated vasculitis: chest CT patterns and correlation with survival. Semin Arthritis Rheum. 2025, 73:152726. 10.1016\/j.semarthrit.2025.152726","journal-title":"Semin Arthritis Rheum"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-024-03423-w","article-title":"Clinical features, radiological findings and prognosis of microscopic polyangiitis with interstitial lung disease: a retrospective matched control study","volume":"24","author":"Song Q","year":"2024","unstructured":"Song Q, Liu Y, Wu T, Zhang Y, Yan Y, Xiao S. Clinical features, radiological findings and prognosis of microscopic polyangiitis with interstitial lung disease: a retrospective matched control study. BMC Pulm Med. 2024, 24:605. 10.1186\/s12890-024-03423-w","journal-title":"BMC Pulm Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-025-01756-2","article-title":"A closer look to the lung involvement in ANCA-associated vasculitis: alveolar haemorrhage and interstitial lung disease","volume":"25","author":"Kaya MN","year":"2025","unstructured":"Kaya MN, K\u0131l\u0131\u00e7 \u00d6, Y\u0131lmaz S. A closer look to the lung involvement in ANCA-associated vasculitis: alveolar haemorrhage and interstitial lung disease. Clin Exp Med. 2025, 25:335. 10.1007\/s10238-025-01756-2","journal-title":"Clin Exp Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-45027-0","article-title":"Outcomes and prognosis of progressive pulmonary fibrosis in patients with antineutrophil cytoplasmic antibody-positive interstitial lung disease","volume":"13","author":"Sakamoto S","year":"2023","unstructured":"Sakamoto S, Suzuki A, Homma S, et al.. Outcomes and prognosis of progressive pulmonary fibrosis in patients with antineutrophil cytoplasmic antibody-positive interstitial lung disease. Sci Rep. 2023, 13:17616. 10.1038\/s41598-023-45027-0","journal-title":"Sci Rep"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.resmer.2024.101111","article-title":"Interstitial lung diseases associated with ANCA positivity: a different disease spectrum from interstitial pneumonia with autoimmune features","volume":"86","author":"Zhu W","year":"2024","unstructured":"Zhu W, Zhou C, Sun X, et al.. Interstitial lung diseases associated with ANCA positivity: a different disease spectrum from interstitial pneumonia with autoimmune features. Respir Med Res. 2024, 86:101111. 10.1016\/j.resmer.2024.101111","journal-title":"Respir Med Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-024-03453-z","article-title":"Poor prognostic factors for relapse of interstitial lung disease in microscopic polyangiitis: the Japanese multicentre REVEAL cohort study","volume":"26","author":"Matsuda S","year":"2024","unstructured":"Matsuda S, Kotani T, Okazaki A, et al.. Poor prognostic factors for relapse of interstitial lung disease in microscopic polyangiitis: the Japanese multicentre REVEAL cohort study. Arthritis Res Ther. 2024, 26:221. 10.1186\/s13075-024-03453-z","journal-title":"Arthritis Res Ther"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-022-06388-5","article-title":"Clinical differences among patients with myeloperoxidase-antineutrophil cytoplasmic antibody-positive interstitial lung disease","volume":"42","author":"Yamaguchi K","year":"2023","unstructured":"Yamaguchi K, Yamaguchi A, Ito M, et al.. Clinical differences among patients with myeloperoxidase-antineutrophil cytoplasmic antibody-positive interstitial lung disease. Clin Rheumatol. 2023, 42:479-88. 10.1007\/s10067-022-06388-5","journal-title":"Clin Rheumatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1717889","article-title":"Challenging manifestations of ANCA-associated vasculitis treated with avacopan: two case reports","volume":"16","author":"Chalkia A","year":"2025","unstructured":"Chalkia A, Politi A, Tryfonos I, Koutsianas C, Gakiopoulou H, Vassilopoulos D, Petras D. Challenging manifestations of ANCA-associated vasculitis treated with avacopan: two case reports. Front Immunol. 2025, 16:1717889. 10.3389\/fimmu.2025.1717889","journal-title":"Front Immunol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s13730-022-00717-y","article-title":"MPO-ANCA-positive conversion and microscopic polyangiitis development in idiopathic interstitial pneumonia: a case report","volume":"12","author":"Nakayama S","year":"2023","unstructured":"Nakayama S, Endo A, Hirose T, et al.. MPO-ANCA-positive conversion and microscopic polyangiitis development in idiopathic interstitial pneumonia: a case report. CEN Case Rep. 2023, 12:39-44. 10.1007\/s13730-022-00717-y","journal-title":"CEN Case Rep"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.resinv.2024.11.006","article-title":"Clinical characteristics and prognostic factors for MPO-ANCA positive interstitial lung disease: a comparative study of ANCA associated vasculitis (AAV)-ILD and pulmonary limited vasculitis","volume":"63","author":"Shimamura T","year":"2025","unstructured":"Shimamura T, Furusawa H, Ejima M, Ozawa A, Adachi T, Tateishi U, Miyazaki Y. Clinical characteristics and prognostic factors for MPO-ANCA positive interstitial lung disease: a comparative study of ANCA associated vasculitis (AAV)-ILD and pulmonary limited vasculitis. Respir Investig. 2025, 63:1-6. 10.1016\/j.resinv.2024.11.006","journal-title":"Respir Investig"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10122548","article-title":"Interstitial lung disease and anti-myeloperoxidase antibodies: not a simple association","volume":"10","author":"Sebastiani M","year":"2021","unstructured":"Sebastiani M, Luppi F, Sambataro G, et al.. Interstitial lung disease and anti-myeloperoxidase antibodies: not a simple association. J Clin Med. 2021, 10:2548. 10.3390\/jcm10122548","journal-title":"J Clin Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-021-05964-5","article-title":"Patterns of lung diseases predict survival in patients with MPO-ANCA-associated vasculitis: a single-center retrospective study","volume":"41","author":"Yang S","year":"2022","unstructured":"Yang S, Chai D, Li Y, et al.. Patterns of lung diseases predict survival in patients with MPO-ANCA-associated vasculitis: a single-center retrospective study. Clin Rheumatol. 2022, 41:783-93. 10.1007\/s10067-021-05964-5","journal-title":"Clin Rheumatol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac339","article-title":"Interstitial lung disease in ANCA-associated vasculitis: associated factors, radiographic features and mortality","volume":"62","author":"Doliner B","year":"2023","unstructured":"Doliner B, Rodriguez K, Montesi SB, Fu X, Sharma A, Wallace ZS. Interstitial lung disease in ANCA-associated vasculitis: associated factors, radiographic features and mortality. Rheumatology (Oxford). 2023, 62:716-25. 10.1093\/rheumatology\/keac339","journal-title":"Rheumatology (Oxford)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2018.02.024","article-title":"Distinctive characteristics and prognostic significance of interstitial pneumonia with autoimmune features in patients with chronic fibrosing interstitial pneumonia","volume":"137","author":"Yoshimura K","year":"2018","unstructured":"Yoshimura K, Kono M, Enomoto Y, et al.. Distinctive characteristics and prognostic significance of interstitial pneumonia with autoimmune features in patients with chronic fibrosing interstitial pneumonia. Respir Med. 2018, 137:167-75. 10.1016\/j.rmed.2018.02.024","journal-title":"Respir Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/494750-myeloperoxidase-antineutrophil-cytoplasmic-antibody-mpo-anca-associated-usual-interstitial-pneumonia-pathogenic-mechanisms-diagnostic-challenges-and-clinical-implications","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T16:11:04Z","timestamp":1778602264000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/494750-myeloperoxidase-antineutrophil-cytoplasmic-antibody-mpo-anca-associated-usual-interstitial-pneumonia-pathogenic-mechanisms-diagnostic-challenges-and-clinical-implications"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.108728","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,12]]}}}